Autres langues Zomedica Corp.

Actions

ZOM

CA98980M1095

Marché Fermé - Nyse Autres places de cotation 22:00:00 02/05/2024			Varia. 5j.	Varia. 1 janv.
0,142 ^USD	+0,28%		+9,15%	-29,07%

01/04	Zomedica Corp. annonce ses résultats pour l'exercice clos le 31 décembre 2023	CI
01/04	Zomedica cherche à faire des acquisitions	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Zomedica Strengthens Market Position with New Patents Issued for its TRUFORMA Diagnostic Platform	12:59
Zomedica to Report First Quarter 2024 Financial Results and Provide Business Update on May 9th at 4:30 p.m. ET	01/05
Zomedica to Present at the Noble Capital Markets Virtual Healthcare Conference on April 17, 2024	10/04
Zomedica Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	01/04
Zomedica Seeks Acquisitions	01/04
Earnings Flash (ZOM) ZOMEDICA Posts Q4 Revenue $7.3M	01/04
Zomedica Corp. Reiterates Revenue Guidance for Full Year 2024	01/04
Zomedica Announces Publication of Research Concluding TRUFORMA Platform is More Accurate Diagnostic Test for Feline Hyperthyroidism than Chemiluminescent Immunoassay Platform	15/03
Zomedica Corp. Announces Publication of Research Con Including TRUFORMA(R) Platform Is More Accurate Diagnostic Test for Feline Hyperthyroidism Than Chemiluminescent Immunoassay Platform	14/03
Zomedica Announces Sponsorship of Educational Presentations at Fetch dvm360 Veterinary Conferences	13/03
Zomedica Announces Publication of Case Series Highlighting Success with PulseVet Shock Wave Therapy for Difficult to Treat Fibrotic Myopathy in Working Dogs	08/03
Zomedica to Present at the Sidoti Small Cap Conference March 14, 2024	06/03
Zomedica Announces Sponsorship of Educational Presentations at Major Veterinary Health Conferences	09/02
Zomedica to Host Virtual Investor Day February 13 at 3:00 p.m. ET	07/02
Open Letter to Zomedica Shareholders from your Chief Executive Officer	01/02
Zomedica to Participate in the Lytham Partners 2024 Investor Select Conference	31/01
Zomedica Pharmaceuticals Reports Preliminary Q4 Revenue	17/01
Zomedica Corp. Provides Revenue Guidance for the Fourth Quarter and Full Year of 2023 and Full Year 2024	17/01
Zomedica Corp. to Host Conference Call on January 17, 2024, at 4:30 p.m. ET to Provide a Business Update, Preliminary 2023 Revenue and Cash Position	11/01
Zomedica Announces Publication of Research Validating Better Patient Acceptance of PulseVet Electro-hydraulic Shock Wave Therapy without Sedation Utilizing Novel 'X-Trode' Handpiece	05/01

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Zomedica Corp.

Actions

ZOM

CA98980M1095

Autres langues

Filtres